Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo

NCT04942860 is registered in ClinicalTrials.gov with Nicolaus Copernicus University as lead sponsor.

NCT NCT04942860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04942860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo
Lead sponsor
Nicolaus Copernicus University
Phase
Phase 3
Overall status
Completed
Start date
October 1, 2019
Completion date
August 31, 2023
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-segmental vitiligo